MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors

Cell Transplantation

Volumn 23, Issue 4-5, 2014, Pages 669-690

  Lee, Yi Yen ^a,b   Yang, Yi Ping ^a,b   Huang, Ming Chao ^a,b   Wang, Mong Lien ^a   Yen, Sang Hue ^a,b   Huang, Pin I ^a,b   Chen, Yi Wei ^a,b   Chiou, Shih Hwa ^a,b   Lan, Yuan Tzu ^a,b   Ma, Hsin I ^c   Shih, Yang Hsin ^a,b   Chen, Ming Teh ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Atypical teratoid rhabdoid tumor (ATRT); Cancer stem cells (CSCs); Cluster of differentiation 133 (CD133); Pediatric brain tumor; Radiosensitivity

Indexed keywords

CD133 ANTIGEN; MICRORNA; MICRORNA 142 3P; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; ADENYLATE CYCLASE; ADENYLATE CYCLASE 9; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; MIRN142 MICRORNA, HUMAN; PEPTIDE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CANCER; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL RENEWAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INFANT; MALE; MEDULLOBLASTOMA; MESENCHYMAL STEM CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOID TUMOR; SURVIVAL TIME; TERATOMA; TUMOR GROWTH; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BRAIN NEOPLASMS; CANCER STEM CELL; CELL MOTION; CELL SURVIVAL; CYTOLOGY; EMBRYONIC STEM CELL; GAMMA RADIATION; GENETICS; IONIZING RADIATION; MESENCHYMAL STROMA CELL; METABOLISM; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; PRESCHOOL CHILD; RADIATION RESPONSE; TUMOR CELL CULTURE;

ADENYLATE CYCLASE; ADOLESCENT; ANIMALS; ANTIGENS, CD; BASE SEQUENCE; BRAIN NEOPLASMS; CELL MOVEMENT; CELL SURVIVAL; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; EMBRYONIC STEM CELLS; FEMALE; GAMMA RAYS; GLYCOPROTEINS; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASTIC STEM CELLS; PEPTIDES; RADIATION, IONIZING; TUMOR CELLS, CULTURED;

EID: 84900453296     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368914X678364     Document Type: Article

References (45)

1. Bao, S.; Wu, Q.; McLendon, R. E.; Hao, Y.; Shi, Q.; Hjelmeland, A. B.; Dewhirst, M. W.; Bigner, D. D.; Rich, J. N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756-760; 2006.
2. + cells display stem-like features and are spared by cisplatin treatment. Proc. Natl. Acad. Sci. USA 106(38):16281-16286; 2009.
3. Bikowska, B.; Grajkowska, W.; Jozwiak, J. Atypical teratoid/ rhabdoid tumor: Short clinical description and insight into possible mechanism of the disease. Eur. J. Neurol. 18(6):813-818; 2011.
4. + sector is enlarged by hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 67(1):1-5; 2007.
5. Burger, P. C.; Yu, I. T.; Tihan, T.; Friedman, H. S.; Strother, D. R.; Kepner, J. L.; Duffner, P. K.; Kun, L. E.; Perlman, E. J. Atypical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: A Pediatric Oncology Group study. Am. J. Surg. Pathol. 22(9):1083-1092; 1998.
6. Carro, M. S.; Lim, W. K.; Alvarez, M. J.; Bollo, R. J.; Zhao, X.; Snyder, E. Y.; Sulman, E. P.; Anne, S. L.; Doetsch, F.; Colman, H.; Lasorella, A.; Aldape, K.; Califano, A.; Iavarone, A. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463(7279):318-325; 2010.
7. Chen, C. Z.; Li, L.; Lodish, H. F.; Bartel, D. P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303(5654):83-86; 2004.
8. Chen, Y. C.; Hsu, H. S.; Chen, Y. W.; Tsai, T. H.; How, C. K.; Wang, C. Y.; Hung, S. C.; Chang, Y. L.; Tsai, M. L.; Lee, Y. Y.; Ku, H. H.; Chiou, S. H. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 3(7):e2637; 2008.
9. Chiou, S. H.; Kao, C. L.; Chen, Y. W.; Chien, C. S.; Hung, S. C.; Lo, J. F.; Chen, Y. J.; Ku, H. H.; Hsu, M. T.; Wong, T. T. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS One 3(5):e2090; 2008.
10. Chiou, S. H.; Kao, C. L.; Peng, C. H.; Chen, S. J.; Tarng, Y. W.; Ku, H. H.; Chen, Y. C.; Shyr, Y. M.; Liu, R. S.; Hsu, C. J.; Yang, D. M.; Hsu, W. M.; Kuo, C. D.; Lee, C. H. A novel in vitro retinal differentiation model by co-culturing adult human bone marrow stem cells with retinal pigmented epithelium cells. Biochem. Biophys. Res. Commun. 326(3): 578-585; 2005.
11. Croce, C. M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10(10):704-714; 2009.
12. Das, B.; Tsuchida, R.; Malkin, D.; Koren, G.; Baruchel, S.; Yeger, H. Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 26(7):1818-1830; 2008.
13. Ding, D. C.; Shyu, W. C.; Lin, S. Z.; Liu, H. W.; Chiou, S. H.; Chu, T. Y. Human umbilical cord mesenchymal stem cells support nontumorigenic expansion of human embryonic stem cells. Cell Transplant. 21(7):1515-1527; 2012.
14. Ebert, M. S.; Neilson, J. R.; Sharp, P. A. MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4(9):721-726; 2007.
15. Eramo, A.; Lotti, F.; Sette, G.; Pilozzi, E.; Biffoni, M.; Di Virgilio, A.; Conticello, C.; Ruco, L.; Peschle, C.; De Maria, R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15(3):504-514; 2008.
16. Ferretti, E.; De Smaele, E.; Miele, E.; Laneve, P.; Po, A.; Pelloni, M.; Paganelli, A.; Di Marcotullio, L.; Caffarelli, E.; Screpanti, I.; Bozzoni, I.; Gulino, A. Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J. 27(19):2616-2627; 2008.
17. Galli, R.; Binda, E.; Orfanelli, U.; Cipelletti, B.; Gritti, A.; De Vitis, S.; Fiocco, R.; Foroni, C.; Dimeco, F.; Vescovi, A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64(19):7011-7021; 2004.
18. Garzia, L.; Andolfo, I.; Cusanelli, E.; Marino, N.; Petrosino, G.; De Martino, D.; Esposito, V.; Galeone, A.; Navas, L.; Esposito, S.; Gargiulo, S.; Fattet, S.; Donofrio, V.; Cinalli, G.; Brunetti, A.; Vecchio, L. D.; Northcott, P. A.; Delattre, O.; Taylor, M. D.; Iolascon, A.; Zollo, M. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS One 4(3):e4998; 2009.
19. Gillies, J. K.; Lorimer, I. A. Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 6(16):2005-2009; 2007.
20. Ho, D. M.; Hsu, C. Y.; Wong, T. T.; Ting, L. T.; Chiang, H. Atypical teratoid/rhabdoid tumor of the central nervous system: A comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol. 99(5):482-488; 2000.
21. Ho, M. M.; Ng, A. V.; Lam, S.; Hung, J. Y. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 67(10):4827-4833; 2007.
22. Huse, J. T.; Brennan, C.; Hambardzumyan, D.; Wee, B.; Pena, J.; Rouhanifard, S. H.; Sohn-Lee, C.; le Sage, C.; Agami, R.; Tuschl, T.; Holland, E. C. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 23(11):1327-1337; 2009.
23. Iliopoulos, D.; Lindahl-Allen, M.; Polytarchou, C.; Hirsch, H. A.; Tsichlis, P. N.; Struhl, K. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol. Cell 39(5):761-772; 2010.
24. Ji, J.; Yamashita, T.; Budhu, A.; Forgues, M.; Jia, H. L.; Li, C.; Deng, C.; Wauthier, E.; Reid, L. M.; Ye, Q. H.; Qin, L. X.; Yang, W.; Wang, H. Y.; Tang, Z. Y.; Croce, C. M.; Wang, X. W. Identification of microRNA-181 by genomewide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 50(2):472-480; 2009.
25. Ji, Q.; Hao, X.; Zhang, M.; Tang, W.; Yang, M.; Li, L.; Xiang, D.; Desano, J. T.; Bommer, G. T.; Fan, D.; Fearon, E. R.; Lawrence, T. S.; Xu, L. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 4(8):e6816; 2009.
26. Kao, C. L.; Huang, P. I.; Tsai, P. H.; Tsai, M. L.; Lo, J. F.; Lee, Y. Y.; Chen, Y. J.; Chen, Y. W.; Chiou, S. H. Resveratrolinduced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. Int. J. Radiat. Oncol. Biol. Phys. 74(1):219-228; 2009.
27. Kota, J.; Chivukula, R. R.; O'Donnell, K. A.; Wentzel, E. A.; Montgomery, C. L.; Hwang, H. W.; Chang, T. C.; Vivekanandan, P.; Torbenson, M.; Clark, K. R.; Mendell, J. R.; Mendell, J. T. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137(6):1005-1017; 2009.
28. Packer, R. J.; Biegel, J. A.; Blaney, S.; Finlay, J.; Geyer, J. R.; Heideman, R.; Hilden, J.; Janss, A. J.; Kun, L.; Vezina, G.; Rorke, L. B.; Smith, M. Atypical teratoid/rhabdoid tumor of the central nervous system: Report on workshop. J. Pediatr. Hematol. Oncol. 24(5):337-342; 2002.
29. Qian, S.; Ding, J. Y.; Xie, R.; An, J. H.; Ao, X. J.; Zhao, Z. G.; Sun, J. G.; Duan, Y. Z.; Chen, Z. T.; Zhu, B. MicroRNA expression profile of bronchioalveolar stem cells from mouse lung. Biochem. Biophys. Res. Commun. 377(2):668-673; 2008.
30. Rorke, L. B.; Packer, R. J.; Biegel, J. A. Central nervoussystem atypical teratoid/rhabdoid tumors of infancy and childhood: Definition of an entity. J. Neurosurg. 85(1): 56-65; 1996.
31. Saigusa, S.; Tanaka, K.; Toiyama, Y.; Yokoe, T.; Okugawa, Y.; Ioue, Y.; Miki, C.; Kusunoki, M. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann. Surg. Oncol. 16(12):3488-3498; 2009.
32. Sasayama, T.; Nishihara, M.; Kondoh, T.; Hosoda, K.; Kohmura, E. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int. J. Cancer 125(6):1407-1413; 2009.
33. Shimono, Y.; Zabala, M.; Cho, R. W.; Lobo, N.; Dalerba, P.; Qian, D.; Diehn, M.; Liu, H.; Panula, S. P.; Chiao, E.; Dirbas, F. M.; Somlo, G.; Pera, R. A.; Lao, K.; Clarke, M. F. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138(3):592-603; 2009.
34. Silber, J.; Lim, D. A.; Petritsch, C.; Persson, A. I.; Maunakea, A. K.; Yu, M.; Vandenberg, S. R.; Ginzinger, D. G.; James, C. D.; Costello, J. F.; Bergers, G.; Weiss, W. A.; Alvarez-Buylla, A.; Hodgson, J. G. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 6:14; 2008.
35. Sredni, S. T.; Bonaldo Mde, F.; Costa, F. F.; Huang, C. C.; Hamm, C. A.; Rajaram, V.; Tomita, T.; Goldman, S.; Bischof, J. M.; Soares, M. B. Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: Potential therapeutic targets. Childs Nerv. Syst. 26(3):279-283; 2010.
36. Sun, W.; Shen, W.; Yang, S.; Hu, F.; Li, H.; Zhu, T. H. MiR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-beta. Cell Res. 20(10):1158-1169; 2010.
37. Sutter, R.; Shakhova, O.; Bhagat, H.; Behesti, H.; Sutter, C.; Penkar, S.; Santuccione, A.; Bernays, R.; Heppner, F. L.; Schuller, U.; Grotzer, M.; Moch, H.; Schraml, P.; Marino, S. Cerebellar stem cells act as medulloblastomainitiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene 29(12):1845-1856; 2010.
38. Tarasenko, Y. I.; Yu, Y.; Jordan, P. M.; Bottenstein, J.; Wu, P. Effect of growth factors on proliferation and phenotypic differentiation of human fetal neural stem cells. J. Neurosci. Res. 78(5):625-636; 2004.
39. Tirino, V.; Camerlingo, R.; Franco, R.; Malanga, D.; La, R. A.; Viglietto, G.; Rocco, G.; Pirozzi, G. The role of CD133 in the identification and characterisation of tumourinitiating cells in non-small-cell lung cancer. Eur. J. Cardiothorac. Surg. 36(3):446-453; 2009.
40. Utsuki, S.; Oka, H.; Tanaka, S.; Kondo, K.; Tanizaki, Y.; Fujii, K. Importance of re-examination for medulloblastoma and atypical teratoid/rhabdoid tumor. Acta Neurochir. 145(8):663-666; discussion 666; 2003.
41. Wakamatsu, Y.; Sakamoto, N.; Oo, H. Z.; Naito, Y.; Uraoka, N.; Anami, K.; Sentani, K.; Oue, N.; Yasui, W. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol. Int. 62(2):112-119; 2012.
42. Wang, X.; Han, L.; Zhang, A.; Wang, G.; Jia, Z.; Yang, Y.; Yue, X.; Pu, P.; Shen, C.; Kang, C. Adenovirus-mediated shRNAs for co-repression of miR-221 and miR-222 expression and function in glioblastoma cells. Oncol. Rep. 25(1): 97-105; 2011.
43. Yin, A. H.; Miraglia, S.; Zanjani, E. D.; Meida-Porada, G.; Ogawa, M.; Leary, A. G.; Olweus, J.; Kearney, J.; Buck, D. W. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90(12):5002-5012; 1997.
44. Yu, F.; Deng, H.; Yao, H.; Liu, Q.; Su, F.; Song, E. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 29(29):4194-4204; 2010.
45. Yuan, W.; Sun, W.; Yang, S.; Du, J.; Zhai, C. L.; Wang, Z. Q.; Zhang, J.; Zhu, T. H. Downregulation of microRNA-142 by proto-oncogene LMO2 and its co-factors. Leukemia 22(5):1067-1071; 2008.